Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Varex Imaging (VREX) Amortization of Goodwill (2025)

Varex Imaging (VREX) reported Amortization of Goodwill of $93.9 million for Q3 2025.

Varex Imaging (VREX) has 1 years of Amortization of Goodwill data on file, last reported at $93.9 million in Q3 2025.

  • Quarterly Amortization of Goodwill changed N/A year-over-year to $93.9 million in Q3 2025, while the trailing twelve-month figure through Oct 2025 was $93.9 million (changed N/A YoY) and the FY2025 annual result came in at $93.9 million, changed N/A from the prior year.
  • Amortization of Goodwill held at $93.9 million in Q3 2025 per VREX's latest filing.
  • Across five years, Amortization of Goodwill topped out at $93.9 million in Q3 2025 and bottomed at $93.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Varex Imaging 419.42 Mn 345.02 Mn 72.60 Mn

Historic Data

Download Data 🔒
DateValue
Jul 4, 2025 93.90 Mn
Jul 4, 2025 93.90 Mn